• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟疾中受感染红细胞表面的抗原变异

Antigenic variation at the infected red cell surface in malaria.

作者信息

Kyes S, Horrocks P, Newbold C

机构信息

Molecular Parasitology Group, Weatherall Institute of Molecular Medicine, Headington, Oxford OX3 9DS United Kingdom.

出版信息

Annu Rev Microbiol. 2001;55:673-707. doi: 10.1146/annurev.micro.55.1.673.

DOI:10.1146/annurev.micro.55.1.673
PMID:11544371
Abstract

Many pathogens that either rely on an insect vector to complete their life cycle (e.g., Trypanosoma spp. and Borrelia spp.) or exist in a unique ecological niche where transmission from host to host is sporadic (e.g., Neisseria spp.) have evolved strategies to maintain infection of their mammalian hosts for long periods of time in order to ensure their survival. Because they have to survive in the face of a fully functional immune system, a common feature of many of these organisms is their development of sophisticated strategies for immune evasion. For the above organisms and for malaria parasites of the genus Plasmodium, a common theme is the ability to undergo clonal antigenic variation. In all cases, surface molecules that are important targets of the humoral immune response are encoded in the genome as multicopy, nonallelic gene families. Antigenic variation is accomplished by the successive expression of members of these gene families that show little or no immunological cross-reactivity. In the case of malaria parasites, however, some of the molecules that undergo antigenic variation are also major virulence factors, adding an additional level of complication to the host-parasite interaction. In this review, we cover the history of antigenic variation in malaria and then summarize the more recent data with particular emphasis on Plasmodium falciparum, the etiological agent of the most severe form of human malaria.

摘要

许多病原体,要么依赖昆虫媒介来完成其生命周期(如锥虫属和疏螺旋体属),要么存在于独特的生态位中,宿主间的传播是零星发生的(如奈瑟菌属),它们已经进化出一些策略,以便长时间维持对其哺乳动物宿主的感染,从而确保自身的生存。由于它们必须在功能完备的免疫系统面前存活下来,这些生物体中的许多都有一个共同特征,即它们会发展出复杂的免疫逃避策略。对于上述生物体以及疟原虫属的疟原虫来说,一个共同的主题是能够进行克隆性抗原变异。在所有情况下,作为体液免疫反应重要靶标的表面分子,在基因组中被编码为多拷贝、非等位基因家族。抗原变异是通过这些基因家族成员的相继表达来实现的,这些成员之间几乎没有或没有免疫交叉反应。然而,就疟原虫而言,一些发生抗原变异的分子也是主要的毒力因子,这给宿主 - 寄生虫相互作用增添了额外的复杂性。在这篇综述中,我们涵盖了疟疾抗原变异的历史,然后总结了最新的数据,特别强调了恶性疟原虫,它是人类最严重形式疟疾的病原体。

相似文献

1
Antigenic variation at the infected red cell surface in malaria.疟疾中受感染红细胞表面的抗原变异
Annu Rev Microbiol. 2001;55:673-707. doi: 10.1146/annurev.micro.55.1.673.
2
Parasite immune escape: new views into host-parasite interactions.寄生虫免疫逃逸:宿主 - 寄生虫相互作用的新视角
Curr Opin Microbiol. 2005 Aug;8(4):428-33. doi: 10.1016/j.mib.2005.06.011.
3
The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum.人类疟原虫恶性疟原虫中基因扩增、多样化及高变异性的种类
Mol Biochem Parasitol. 2009 Aug;166(2):109-16. doi: 10.1016/j.molbiopara.2009.04.003. Epub 2009 Apr 16.
4
Variant antigen gene expression in malaria.疟疾中变异抗原基因的表达
Cell Microbiol. 2006 Sep;8(9):1371-81. doi: 10.1111/j.1462-5822.2006.00760.x. Epub 2006 Jul 18.
5
Variant surface antigens of Plasmodium falciparum and their roles in severe malaria.恶性疟原虫表面抗原变异及其在重症疟疾中的作用。
Nat Rev Microbiol. 2017 Aug;15(8):479-491. doi: 10.1038/nrmicro.2017.47. Epub 2017 Jun 12.
6
Antigenic Variation in Plasmodium falciparum.恶性疟原虫的抗原变异
Results Probl Cell Differ. 2015;57:47-90. doi: 10.1007/978-3-319-20819-0_3.
7
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria.短暂的交叉反应性免疫应答可调控疟疾中的抗原变异。
Nature. 2004 Jun 3;429(6991):555-8. doi: 10.1038/nature02486.
8
Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?疟疾中的抗原多态性:它是免疫逃避的重要机制吗?
Immunol Today. 1991 Mar;12(3):A34-7. doi: 10.1016/S0167-5699(05)80010-6.
9
PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum.恶性疟原虫红细胞膜蛋白1(PfEMP1):一种在恶性疟原虫致病性和免疫逃逸中起关键作用的抗原。
Int J Biochem Cell Biol. 2009 Jul;41(7):1463-6. doi: 10.1016/j.biocel.2008.12.012. Epub 2008 Dec 25.
10
Antigenic variation and immune evasion in Plasmodium falciparum malaria.恶性疟原虫疟疾中的抗原变异与免疫逃避
Immunol Cell Biol. 1996 Dec;74(6):546-54. doi: 10.1038/icb.1996.88.

引用本文的文献

1
Comparative transcriptomics reveal stage-dependent parasitic adaptations in the myxozoan Sphaerospora molnari.比较转录组学揭示了粘孢子虫莫氏球孢虫阶段依赖性的寄生适应性。
BMC Genomics. 2025 Feb 3;26(1):103. doi: 10.1186/s12864-025-11265-x.
2
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).SEVUparin作为重症疟疾儿童潜在辅助治疗方法:一项I期安全性和剂量探索试验(SEVUSMAART)。
Wellcome Open Res. 2024 Aug 12;8:484. doi: 10.12688/wellcomeopenres.20111.2. eCollection 2023.
3
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
针对肿瘤相关的癌症治疗使用针对癌胚软骨素硫酸盐的抗体。
Nat Commun. 2024 Aug 30;15(1):7553. doi: 10.1038/s41467-024-51781-0.
4
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial).一项针对脑型疟疾患儿的无创通气与左乙拉西坦预防癫痫发作的I期试验(NOVICE-M试验)。
Wellcome Open Res. 2024 May 20;9:281. doi: 10.12688/wellcomeopenres.21403.1. eCollection 2024.
5
A landscape review of malaria vaccine candidates in the pipeline.对正在研发的疟疾疫苗候选物的全景综述。
Trop Dis Travel Med Vaccines. 2024 Aug 1;10(1):19. doi: 10.1186/s40794-024-00222-3.
6
A new mechanism of antibody diversity: formation of the natural antibodies containing LAIR1 and LILRB1 extracellular domains.抗体多样性的一种新机制:包含LAIR1和LILRB1细胞外结构域的天然抗体的形成。
Antib Ther. 2024 May 21;7(2):157-163. doi: 10.1093/abt/tbae008. eCollection 2024 Apr.
7
Proteomes of plasmodium knowlesi early and late ring-stage parasites and infected host erythrocytes.疟原虫 knowlesi 早期和晚期环早期寄生虫和感染宿主红细胞的蛋白质组。
J Proteomics. 2024 Jun 30;302:105197. doi: 10.1016/j.jprot.2024.105197. Epub 2024 May 15.
8
Uncovering the role of Rad51 in homologous recombination-mediated antigenic diversification in the human malaria parasite .揭示Rad51在人类疟原虫同源重组介导的抗原多样化中的作用。
Front Mol Biosci. 2023 Aug 1;10:1223682. doi: 10.3389/fmolb.2023.1223682. eCollection 2023.
9
infection reshapes the human microRNA profiles of red blood cells and their extracellular vesicles.感染重塑红细胞及其细胞外囊泡的人类微小RNA谱。
iScience. 2023 Jun 15;26(7):107119. doi: 10.1016/j.isci.2023.107119. eCollection 2023 Jul 21.
10
Innate immunity to malaria: The good, the bad and the unknown.先天免疫对疟疾:好、坏与未知。
Front Immunol. 2022 Aug 19;13:914598. doi: 10.3389/fimmu.2022.914598. eCollection 2022.